Article Details

Pfizer Presents Real-World Evidence of Ibrance for HR+, HER- Breast Cancer - Pharmacy Times

Retrieved on: 2022-05-06 13:22:43

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Presents Real-World Evidence of Ibrance for HR+, HER- Breast Cancer - Pharmacy Times. View article details on HISWAI: https://www.pharmacytimes.com/view/pfizer-presents-real-world-evidence-of-ibrance-for-hr-her--breast-cancer

Excerpt

“Since its approval, palbociclib has generated promising results for adults diagnosed with HR+, HER2- mBC, and this latest analysis reflects Pfizer's ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up